Edible Vaccine Market 2026, Demand, Size And Market Insights

What Are The Estimated Market Size And CAGR For The Edible Vaccine Market Between 2026 And 2030?
The edible vaccine market size has grown strongly in recent years. It will grow from $9.51 billion in 2025 to $10.35 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to progress in genetic engineering techniques, early research in transgenic plants for vaccines, expansion of public health immunization programs, increasing funding for alternative vaccine platforms, initial clinical validation studies.

The edible vaccine market size is expected to see strong growth in the next few years. It will grow to $14.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for needle-free vaccination solutions, rising investments in edible vaccine clinical trials, expansion of livestock immunization programs, growing focus on global vaccine accessibility, advancements in regulatory approval pathways. Major trends in the forecast period include advancements in plant-based vaccine expression systems, growing focus on oral vaccine delivery methods, expansion of low-cost vaccine production models, increasing research on heat-stable vaccines, rising collaboration between biotech and agricultural sectors.

Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19040&type=smp

What Essential Growth Drivers Are Pushing The Edible Vaccine Market Forward?
The increasing prevalence of infectious diseases is expected to propel the growth of the edible vaccine market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that invade the body and multiply. The increasing prevalence of infectious diseases is mainly due to factors such as globalization, climate change, urbanization, and antibiotic resistance, which facilitate the spread and emergence of new pathogens. Edible vaccines are used in infectious diseases to stimulate immune responses by consuming genetically modified foods that produce antigens, offering a cost-effective and needle-free method of immunization. For instance, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, the number of tuberculosis cases rose from 8, 320 in 2022 to 9, 615 in 2023, representing an increase of 1, 295 cases. Additionally, the rate per 100, 000 people went up from 2.5 in 2022 to 2.9 in 2023. Therefore, the increasing prevalence of infectious diseases is driving the growth of the edible vaccine market.



Which Segment Groups Play A Crucial Role In Outlining The Edible Vaccine Market’s Structure?
The edible vaccine market covered in this report is segmented –

1) By Vaccine Type: Subunit Vaccines, Virus-Like Particle VLP Vaccines, Plant-Expressed Antigen Vaccines, Recombinant Protein Vaccines, Other Edible Vaccine Types
2) By Source: Fruits, Vegetables, Cereal Grains, Legumes, Other Edible Plants
3) By Route of Administration: Oral Fresh Plant Consumption, Oral Processed Edible Form Feed, Sublingual And Buccal Edible Extract-Based
4) By Distribution Model: Public Health And Immunization Programs, Veterinary And Animal Health Programs, Direct Farm-Level Administration, Research And Academic Institutions
5) By Application: Human Immunization, Veterinary Vaccines, Livestock, Poultry, Aquaculture Vaccines, Other Applications
6) By End User: Adults, Pediatrics, Animals

Subsegments:
1) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines, Conjugated Subunit Vaccines
2) By Virus-Like Particle (VLP) Vaccines: Plant-Derived VLP Vaccines, Chimeric VLP Vaccines, Multi-Antigen VLP Vaccines
3) By Plant-Expressed Antigen Vaccines: Fruit-Based Edible Vaccines, Vegetable-Based Edible Vaccines, Grain-Based Edible Vaccines, Legume-Based Edible Vaccines
4) By Recombinant Protein Vaccines: Recombinant Bacterial Antigen Vaccines, Recombinant Viral Antigen Vaccines, Recombinant Parasitic Antigen Vaccines
5) By Other Edible Vaccine Types: Oral Mucosal Immunity-Targeted Vaccines, Multi-Epitope Edible Vaccines, Combination Edible Vaccines

Which Strategic Trends Are Likely To Impact Competitive Positioning In The Edible Vaccine Market?
Major companies operating in the edible vaccine market are focusing on developing innovative solutions, such as oral cholera vaccine (OCV), to combat the global cholera crisis. Oral cholera vaccine (OCV) is a type of vaccine administered by mouth to prevent cholera, a severe diarrheal disease caused by the bacterium Vibrio cholerae. For instance, in August 2024, Bharat Biotech International Limited, an India-based biotechnology company, launched the Hillchol, an oral cholera vaccine (OCV) with several notable features. This live-attenuated vaccine stimulates both systemic and mucosal immune responses, protecting against cholera. Hillchol stands out for its ease of administration and does not require cold storage, making it ideal for use in resource-limited settings. Moreover, it offers long-lasting immunity with just a single dose.

Which Companies Represent The Key Strategic Forces Within The Edible Vaccine Market?
Major companies operating in the edible vaccine market are Medicago Inc., Vaxart Inc., Vaxiion Therapeutics Inc., Mymetics Corporation, Profectus BioSciences Inc., GreenLight Biosciences Inc., Akston Biosciences Corporation, Icon Genetics GmbH, iBio Inc., Kentucky BioProcessing Inc., Fraunhofer USA Center for Molecular Biotechnology, Nomad Bioscience GmbH, Baiya Phytopharm Company Limited, Dow AgroSciences LLC, GenCure Biomanufacturing, Transgene SA, PlantForm Corporation, BioBetter Ltd., Moolec Science SA, Agrenvec SL

Get Your In-Depth Edible Vaccine Market Report Now:
https://www.thebusinessresearchcompany.com/report/edible-vaccine-global-market-report

What Are The Fastest-Expanding Regions Contributing To The Growth Of The Edible Vaccine Market?
North America was the largest region in the edible vaccine market in 2025. The regions covered in the edible vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company